PlusFinancial Times
Access Selected Content from Financial Times on Moneycontrol Pro

MARKET NEWS

View More News
English
Specials
MoneycontrolBe a PRO
PlusFinancial Times
Access Selected Content from
Financial Times on Moneycontrol Pro
Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel
you are here: HomeNewsBusinessMoneycontrol Research
  
  1
Last Updated Last Updated : July 27, 2020 / 08:06 PM IST | Source: Moneycontrol.com

Pharma: Trump’s executive orders may possibly provide better market access opportunities

Indian drugmakers such as Cipla, Cadila, Lupin, Dr Reddy’s, Sun Pharma and a few small-sized pharma companies such as Laurus Labs may benefit from a likely revamp of US medicare

Anubhav Sahu

To view the full content of this article, you have to be a Pro:

  • Already a Moneycontrol Pro subscriber?
    Login now »
    Or
    Open in App
  • Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:

What's included:

  • Ad free experience across Platforms
  • 230+ exclusive stories per month
  • Sharpest Opinions & Actionable Insights
  • Exclusive Research & Expert Technical Analysis
  • Daily Newsletter
  • 20+ Technical Picks every week
  • Recovery Tracker
  • Exclusive webinars on varied topics
  • Weekly wrap up and much more!!!
Subscribe to PRO and get unlimited access to premium content at Rs.33/- per month. Use code SUPERPRO